Product Details
Product Name:
TP-472 |
CAS No.:
2079895-62-6 |
Supply Ability:
10g |
Release date:
2025/08/21 |
Product Introduction
Bioactivity
Name | TP-472 |
Description | TP-472 is a selective inhibitor of BRD9 (Kd: 33 nM). |
In vitro | TP-472 has a high potency for BRD9 with Kd of 33 nM and BRD7 with Kd of 0.34 μM, with >30-fold selectivity over other Brds[1]. TP-472 (1 μM, 3 μM; 24-216 hours) yields concentration-dependent growth defects in ESCs[2]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Keywords | TP-472 | TP472 | TP 472 | EpigeneticReaderDomain | Epigenetic Reader Domain | BRD9 |
Inhibitors Related | ABBV-744 | CeMMEC1 | 3-methyl-1,2,3,4-tetrahydroquinazolin-2-one | (+)-JQ-1 | J-147 | Anacardic Acid | Curcumin | dBET6 | Piflufolastat | Naphthol AS-E | Bisdemethoxycurcumin | GSK1379725A |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:1454299-21-8
$393.00 / 5mg
-
CAS:1976038-41-1
$1980.00 / 50mg
-
CAS:898563-00-3
$84.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$1980.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 |
|
$31.00/10mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-09-15 |
|
$0.00/1BOX |
VIP1Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2024-11-11 |